HTG Molecular Diagnostics to Feature Its HTG EdgeSeq Precision Immuno-Oncology Panel at Booth #4113 at the American Society of Clinical Oncology (ASCO) Conference in June 2018

The Panel will be available to researchers as part of an early access program TUCSON, Ariz. , May 10, 2018 (GLOBE NEWSWIRE) – HTG Molecular Diagnostics , Inc. (Nasdaq:HTGM) (HTG), a provider of instruments, reagents, and services for molecular profiling applications, today announced that it will